A

California bill aimed at providing transparency into prescription drug pricing moved a step closer to reality on Wednesday when a Senate committee approved the legislation.

In a 7 to 2 vote, the state’s Senate Health Committee supported the idea that drug makers should notify state officials about planned price hikes and also justify those increases. The legislation would also require health plans to provide detailed information about drug costs and the portion of premiums attributed to this expense.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.